| Ashley Dawn Marie Baumeister, | |
|
123 S 27th St, Billings, MT 59101-4227 | |
| (406) 247-3360 | |
| (406) 247-3361 |
| Full Name | Ashley Dawn Marie Baumeister |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Case Management |
| Location | 123 S 27th St, Billings, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013770734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0400X | Registered Nurse - Case Management | NUR-RN-LIC-130110 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Dawn Marie Baumeister, 123 S 27th St, Billings, MT 59101-4227 Ph: (406) 247-3362 | Ashley Dawn Marie Baumeister, 123 S 27th St, Billings, MT 59101-4227 Ph: (406) 247-3360 |
News Archive
GlycoMimetics, Inc., a clinical-stage biotechnology company developing a new class of glycobiology-based therapies for a broad range of indications, today announced that the U. S. Patent and Trademark Office has issued two patents covering the company's lead drug candidate and related compounds. One patent, US number 7,728,117, specifically covers GMI-1070, the Company's drug candidate now in clinical trials of patients with vaso-occlusive crisis of sickle cell disease. The second patent, US number 7,741,312, contains claims covering a family of molecules that includes and extends beyond GMI-1070.
Research from The Cancer Institute of New Jersey shows that U.S. Hispanics who speak English are less likely to engage in skin cancer prevention practices and more likely to put themselves at risk for skin cancer as compared to Spanish-speaking Hispanics who live in this country.
Promotoras — volunteer "health promoters" … carry messages of health and wellness to their peers, mostly Spanish-speaking Mexicans in South Philadelphia. As the minority group least likely to have a primary-care doctor and with nearly half living beneath the poverty line, Latinos, especially recent immigrants, have challenged doctors for decades.
Pharmasset, Inc. announced today that safety and pharmacokinetic data from the PSI-352938 single ascending dose study support progression to a multiple ascending dose trial with PSI-938, which has initiated dosing. PSI-938 is a guanine nucleotide analog polymerase inhibitor for the treatment of chronic hepatitis C virus infection.
The global battle against antibiotic resistance can only succeed if local contexts are taken into account. "A tailored approach is needed in each country," says Heiman Wertheim of Radboud university medical center. "There is no "one-size-fits-all' solution."
› Verified 1 days ago
Karmen Hammermeister, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3382 | |
Korbin Johnson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2800 10th Ave N, Billings, MT 59101 Phone: 406-238-2500 | |
Asta Reindl, PMHNP Registered Nurse Medicare: Medicare Enrolled Practice Location: 1601 Lewis Ave Ste 102, Billings, MT 59102 Phone: 206-200-8471 Fax: 833-465-3766 | |
Frannie Nichole Shaub, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 123 S 27th St, Billings, MT 59101 Phone: 406-247-3350 | |
Alicia R Blank, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2040 Rosebud Dr, Billings, MT 59102 Phone: 406-969-4812 Fax: 406-969-4814 | |
Jon M Deim, CSA Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2825 8th Ave N, Billings, MT 59101 Phone: 406-238-2500 |